scholarly article | Q13442814 |
P50 | author | Dong H Kim | Q61190275 |
P2093 | author name string | D. H. Moore | |
M. D. Prados | |||
B. G. Feuerstein | |||
K. Lamborn | |||
A. W. Bollen | |||
G. Mohapatra | |||
P2860 | cites work | Karyotypes in 90 human gliomas | Q48538978 |
Increasing annual incidence of primary malignant brain tumors in the elderly | Q48878157 | ||
Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. | Q53478421 | ||
Detection of complex genetic alterations in human glioblastoma multiforme using comparative genomic hybridization. | Q55480133 | ||
Amplification of the MET gene in glioma. | Q55481480 | ||
Deletion mapping of chromosome 19 in human gliomas. | Q55481940 | ||
Overexpression and Amplification of .ALPHA.-PDGF Receptor Gene Lacking Exons Coding for a Portion of the Extracellular Region in a Malignant Glioma | Q55483388 | ||
Loss of heterozygosity for distal markers on 22q in human gliomas | Q55483473 | ||
TP53 Gene Mutations and 17p Deletions in Human Astrocytomas | Q55483973 | ||
A cytogenetic study of 53 human gliomas. | Q55485308 | ||
Relationship between the c-myb locus and the 6q-chromosomal aberration in leukemias and lymphomas | Q68752952 | ||
The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias | Q69763285 | ||
The retinoblastoma gene is involved in malignant progression of astrocytomas | Q72853950 | ||
Response | Q94596609 | ||
Of historical interest. General Grant fights cancer | Q95816371 | ||
Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization | Q24564349 | ||
Proceedings of the American Association for Cancer Research | Q27717904 | ||
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
Evolution of the mammalian G protein alpha subunit multigene family | Q28207845 | ||
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers | Q28251857 | ||
Identification of an amplified, highly expressed gene in a human glioma | Q28300727 | ||
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers | Q28306997 | ||
Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors | Q29618818 | ||
Molecular genetics of neurological tumours | Q30495393 | ||
Increasing incidence of primary malignant brain tumors: influence of diagnostic methods | Q30961584 | ||
Mitotic recombination of chromosome 17 in astrocytomas | Q33851092 | ||
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. | Q34334383 | ||
Comparative study of p53 gene and protein alterations in human astrocytic tumors | Q34355183 | ||
Molecular genetic characterization of CNS tumor oncogenesis | Q35251504 | ||
Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma | Q35586937 | ||
Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma | Q35976014 | ||
Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails | Q37002174 | ||
Cytogenetics of human brain tumors | Q37934625 | ||
Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors | Q39370472 | ||
Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications | Q39495167 | ||
A tiger behind many doors: multiple genetic pathways to malignant glioma | Q40372189 | ||
Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization. | Q40991079 | ||
Computer image analysis of comparative genomic hybridization. | Q41005524 | ||
Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme | Q41075821 | ||
Multiple sequential molecular abnormalities in the evolution of human gliomas | Q42122831 | ||
Loss of constitutional heterozygosity in chromosome 10 in human glioblastoma | Q42132035 | ||
Loss in expression of the retinoblastoma gene product in human gliomas is associated with advanced disease | Q42809045 | ||
Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization. | Q46416397 | ||
Molecular analysis of genomic abnormalities in human gliomas | Q48143217 | ||
Pediatric malignant glioma with tubuloreticular inclusions and MYCN amplification. Report of a case with immunohistochemical, ultrastructural, flow cytometric, karyotypic, and Southern blot analysis | Q48145215 | ||
Abnormalities of chromosome 22 in human brain tumors determined by combined cytogenetic and molecular genetic approaches | Q48322395 | ||
Prognostic value of cytogenetic analysis in human cerebral astrocytomas | Q48484518 | ||
Loss of heterozygosity on the short arm of chromosome 17 in human astrocytomas | Q48522611 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | glioblastoma | Q282142 |
P304 | page(s) | 195-206 | |
P577 | publication date | 1998-03-01 | |
P1433 | published in | Genes, Chromosomes and Cancer | Q5532697 |
P1476 | title | Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade | |
P478 | volume | 21 |
Q40969242 | Alleletyping of an oligodendrocyte-type-2 astrocyte lineage derive from a human glioblastoma multiforme |
Q30551524 | An integrative characterization of recurrent molecular aberrations in glioblastoma genomes |
Q53211626 | Are neurosurgeons prepared to electively resample glioblastoma in patients without symptomatic relapse? A qualitative study |
Q48111016 | Candidate glioblastoma development gene identification using concordance between copy number abnormalities and gene expression level changes. |
Q48419001 | Chromosomal abnormalities in human glioblastomas: gain in chromosome 7p correlating with loss in chromosome 10q. |
Q35746432 | Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups |
Q34077480 | Chromosome imbalances in familial gliomas detected by comparative genomic hybridization |
Q38472371 | Chromosome transfer experiments link regions on chromosome 7 to radiation resistance in human glioblastoma multiforme |
Q35790323 | Comparative genomic hybridization analysis of astrocytomas: prognostic and diagnostic implications |
Q33653215 | Comparative genomic hybridization and chromosomal instability in solid tumours |
Q48541324 | Comparative genomic hybridization in glioma: a meta-analysis of 509 cases |
Q34693285 | Compilation of published comparative genomic hybridization studies |
Q42680150 | Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components |
Q48603281 | Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH. |
Q35356484 | Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays. |
Q35842067 | Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay |
Q35789635 | Detection of 1p19q Deletion by Real-Time Comparative Quantitative PCR |
Q40806426 | Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization |
Q33253913 | Downregulation of RUNX3 and TES by hypermethylation in glioblastoma |
Q38495020 | Establishment and characterization of chromosomal aberrations in human cholangiocarcinoma cell lines by cross-species color banding |
Q28275738 | Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR |
Q34984218 | Genetic alterations associated with adult diffuse astrocytic tumors |
Q55464979 | Genomic aberrations in 80 cases of primary glioblastoma multiforme: Pathogenetic heterogeneity and putative cytogenetic pathways. |
Q37602543 | Glioblastoma Multiforme Oncogenomics and Signaling Pathways |
Q45978082 | Grade II astrocytomas are subgrouped by chromosome aberrations. |
Q51825686 | Homozygous 10q23/PTEN deletion and its impact on outcome in glioblastoma: a prospective translational study on a uniformly treated cohort of adult patients |
Q34722504 | Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas |
Q55474476 | Identification of extensive genomic loss and gain by comparative genomic hybridisation in malignant astrocytoma in children and young adults. |
Q34152353 | Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors |
Q48144051 | Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype |
Q36021563 | Molecular pathogenesis of oligodendroglial tumors |
Q38233134 | Molecular prognostic factors in glioblastoma: state of the art and future challenges |
Q53616086 | Novel amplicons on the short arm of chromosome 7 identified using high resolution array CGH contain over expressed genes in addition to EGFR in glioblastoma multiforme |
Q35842014 | Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases |
Q31062346 | Prognostic factors for anaplastic astrocytomas |
Q38100640 | Subgrouping of gliomas on the basis of genetic profiles |
Q28391635 | The future role of personalized medicine in the treatment of glioblastoma multiforme |
Q48860319 | The relationship between genetic aberrations as detected by comparative genomic hybridization and vascularization in glioblastoma xenografts |
Q35870360 | Tissue microdissection and degenerate oligonucleotide primed-polymerase chain reaction (DOP-PCR) is an effective method to analyze genetic aberrations in invasive tumors |
Q38411723 | Whole Genome Analysis From Microdissected Tissue Revealed Adult Supratentorial Grade II-III Gliomas Are Divided Into Clinically Relevant Subgroups by Genetic Profile |
Q37170743 | World Health Organization grade II-III astrocytomas consist of genetically distinct tumor lineages |
Search more.